4,943
Views
49
CrossRef citations to date
0
Altmetric
Reviews

Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches

, PhD, , PhD, , PhD, , PhD, , PhD & , PhD
Pages 402-415 | Received 09 Mar 2016, Accepted 06 Jun 2016, Published online: 05 Aug 2016

References

  • Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry Aug 2004;61:807–816.
  • Lai HM, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend Sep 1 2015;154:1–13.
  • Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21(1):14–18.
  • Brady K, Myrick H, Sonne S. Comorbid addiction and affective disorders. Principles of addiction medicine. Arlington, VA: American Society of Addition Medicine; 1998:983–992.
  • Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Practice Perspect 2005;3:13.
  • Brière FN, Rohde P, Seeley JR, Klein D, Lewinsohn PM. Comorbidity between major depression and alcohol use disorder from adolescence to adulthood. Compr Psychiatry 2014;55:526–533.
  • Najt P, Fusar-Poli P, Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Res 2011;186:159–164.
  • Farren CK, Snee L, Daly P, McElroy S. Prognostic factors of 2-year outcomes of patients with comorbid bipolar disorder or depression with alcohol dependence: importance of early abstinence. Alcohol Alcohol 2013;48:93–98.
  • Hawton K, i Comabella CC, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord 2013;147:17–28.
  • Hintz T, Psych D, Mann K. Co-occurring disorders: policy and practice in Germany. Am J Addict 2006;15:261–267.
  • Minkoff K. Best practices: developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatric Serv 2001;52:597–599.
  • Cuellar AK, Johnson SL, Winters R. Distinctions between bipolar and unipolar depression. Clin Psychol Rev 2005;25:307–339.
  • Dobson KS, Khatri N. Cognitive therapy: looking backward, looking forward. J Clin Psychol Jul 2000;56:907–923.
  • Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry Revue Canadienne de Psychiatrie. Jul 2013;58:376–385.
  • McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatric Clin N Am Sep 2010;33:511–525.
  • Riper H, Andersson G, Hunter SB, de Wit J, Berking M, Cuijpers P. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis. Addiction Mar 2014;109:394–406.
  • Hides L, Samet S, Lubman DI. Cognitive behaviour therapy (CBT) for the treatment of co-occurring depression and substance use: current evidence and directions for future research. Drug Alcohol Rev Sep 2010;29:508–517.
  • Baker AL, Thornton LK, Hiles S, Hides L, Lubman DI. Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review. J Affect Disord Aug 2012;139:217–229.
  • Baker AL, Kavanagh DJ, Kay-Lambkin FJ, et al. Randomized controlled trial of cognitive–behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction 2010;105:87–9913p.
  • Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction 2009;104:378–388 311p.
  • Longmore RJ, Worrell M. Do we need to challenge thoughts in cognitive behavior therapy? Clin Psychol Rev Mar 2007;27:173–187.
  • Herbert JD, Forman EM. Caution: the differences between CT and ACT may be larger (and smaller) than they appear. Behav Therapy 2013;44:218–223.
  • Kahl KG, Winter L, Schweiger U. The third wave of cognitive behavioural therapies: what is new and what is effective? Curr Opin Psychiatry 2012;25:522–528.
  • Hollon SD, Kendall PC. Cognitive self-statements in depression: Development of an automatic thoughts questionnaire. Cognit Therapy Res 1980;4:383–395.
  • Barnes-Holmes D, Hayes SC, Dymond S. Self and self-directed rules. Relational frame theory. New York: Springer; 2002:119–139.
  • Hayes SC. Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies. Behav Therapy 2004;35:639–665.
  • Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: Model, processes and outcomes. Behav Res Therapy 2006;44:1–25.
  • Forman EM, Herbert JD, Moitra E, Yeomans PD, Geller PA. A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depression. Behav Modif 2007;31:772–799.
  • Stotts AL, Northrup TF. The promise of third-wave behavioral therapies in the treatment of substance use disorders. Curr Opin Psychol 2015;2:75–81.
  • A-Tjak JGL, Davis ML, Morina N, Powers MB, Smits JAJ, Emmelkamp PMG. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychotherapy Psychosomatics 2015;84:30–36.
  • Öst L-G. The efficacy of acceptance and commitment therapy: an updated systematic review and meta-analysis. Behav Res Therapy 2014;61:105–121.
  • Gifford EV, Kohlenberg BS, Hayes SC, et al. Acceptance-based treatment for smoking cessation. Behav Therapy 2004;35:689–705.
  • Hayes SC, Strosahl K, Wilson KG, et al. Measuring experiential avoidance: a preliminary test of a working model. Psychol Record Fal 2004 2004;54:553–578.
  • Luoma JB, Kohlenberg BS, Hayes SC, Fletcher L. Slow and steady wins the race: a randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders. J Consult Clin Psychol 2012;80:43.
  • Stotts AL, Green C, Masuda A, et al. A stage I pilot study of acceptance and commitment therapy for methadone detoxification. Drug Alcohol Depend 2012;125:215–222.
  • Lanza PV, Garcia PF, Lamelas FR, González‐Menéndez A. Acceptance and commitment therapy versus cognitive behavioral therapy in the treatment of substance use disorder with incarcerated women. J Clin Psychol 2014;70:644–657.
  • Lee EB, An W, Levin ME, Twohig MP. An initial meta-analysis of acceptance and commitment therapy for treating substance use disorders. Drug Alcohol Depend 2015;155:1–7.
  • Petersen CL, Zettle RD. Treating inpatients with comorbid depression and alcohol use disorders: a comparison of acceptance and commitment therapy versus treatment as usual. Psychol Record 2009;59:521.
  • Thekiso TB, Murphy P, Milnes J, Lambe K, Curtin A, Farren CK. Acceptance and commitment therapy in the treatment of alcohol use disorder and comorbid affective disorder: a pilot matched control trial. Behav Therapy 2015;46:717–728.
  • Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment 2006;13:27–45.
  • Bishop SR, Lau M, Shapiro S, et al. Mindfulness: a proposed operational definition. Clin Psychol Sci Practice Fal 2004 2004;11:230–241.
  • Kabat-Zinn J. Full Catastrophic Living: Using the wisdom of your body and mind to face stress, anxiety and depression. New York, NY: Guildford Press; 1990.
  • Kabat-Zinn J, Massion AO, Kristeller J, et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992;149:936–943.
  • Ramel W, Goldin PR, Carmona PE, McQuaid JR. The effects of mindfulness meditation on cognitive processes and affect in patients with past depression. Cognit Therapy Res 2004;28:433–455.
  • Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression. New York: Guilford Press; 2012.
  • Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 2004;72:31.
  • Khoury B, Lecomte T, Fortin G, et al. Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev 2013;33:763–771.
  • Strauss C, Cavanagh K, Oliver A, Pettman D. Mindfulness-based interventions for people diagnosed with a current episode of an anxiety or depressive disorder: a meta-analysis of randomised controlled trials. PLoS One 2014;9:e96110.
  • Karyadi KA, VanderVeen JD, Cyders MA. A meta-analysis of the relationship between trait mindfulness and substance use behaviors. Drug Alcohol Depend 2014;143:1–10.
  • Roos CR, Pearson MR, Brown DB. Drinking motives mediate the negative associations between mindfulness facets and alcohol outcomes among college students. Psychol Addict Behav 2015;29:176.
  • Bowen S, Chawla N, Collins SE, et al. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abuse 2009;30:295–305211.
  • Brewer JA, Bowen S, Smith JT, Marlatt GA, Potenza MN. Mindfulness‐based treatments for co‐occurring depression and substance use disorders: what can we learn from the brain? Addiction 2010;105:1698–1706.
  • Dakwar E, Levin FR. The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders. Harvard Rev Psychiatry 2009;17:254–267.
  • Witkiewitz K, Bowen S, Harrop EN, Douglas H, Enkema M, Sedgwick C. Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change. Subst Use Misuse 2014;49:513–524.
  • Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry 2014;71:547–556.
  • Brewer JA, Sinha R, Chen JA, et al. Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abuse 2009;30:306–317.
  • Carpentier D, Romo L, Bouthillon-Heitzmann P, Limosin F. Résultats préliminaires d’un groupe de pleine conscience (Mindfulness) chez des patients alcoolo-dépendants. L’Encéphale 2015.
  • Zgierska A, Rabago D, Zuelsdorff M, Coe C, Miller M, Fleming M. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. J Addict Med 2008;2:165.
  • Hoppes K. The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders. CNS Spectrums 2006;11:829–851.
  • Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol Jun 2010;78:362–374.
  • Lewinsohn PM. Clinical and theoretical aspects of depression. Innovative treatment methods in psychopathology. New York: Wiley; 1974:63–120.
  • Skinner B. Science and behavior. New York: Macmillan; 1953.
  • Mazzucchelli T, Kane R, Rees C. Behavioral activation treatments for depression in adults: a meta‐analysis and review. Clin Psychol Sci Practice 2009;16:383–411.
  • Mazzucchelli TG, Kane RT, Rees CS. Behavioral activation interventions for well-being: A meta-analysis. J Positive Psychol 2010;5:105–121.
  • Hopko DR, Armento ME, Cantu MS, Chambers LL, Lejuez C. The use of daily diaries to assess the relations among mood state, overt behavior, and reward value of activities. Behav Res Therapy 2003;41:1137–1148.
  • Grosscup SJ, Lewinsohn PM. Unpleasant and pleasant events, and mood. J Clin Psychol 1980;36:252–259.
  • Carvalho JP, Hopko DR. Behavioral theory of depression: Reinforcement as a mediating variable between avoidance and depression. J Behav Therapy Exp Psychiatry 2011;42:154–162.
  • Martell CR, Addis ME, Jacobson NS. Depression in context: Strategies for guided action. New York: W.W. Norton & Co.; 2001.
  • Lejuez CW, Hopko DR, Hopko SD. A brief behavioral activation treatment for depression treatment manual. Behav Modif 2001;25:255–286.
  • Lejuez C, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif 2011;35:111–161.
  • Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy. New York: Guilford Press; 1999.
  • Etten MLV, Higgins ST, Budney AJ, Badger GJ. Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non‐abusers using a standardized behavioral inventory. Addiction 1998;93:1669–1680.
  • Higgins ST, Heil SH, Lussier JP. Clinical implications of reinforcement as a determinant of substance use disorders. Annu Rev Psychol 2004;55:431–461.
  • Carroll ME. Reducing drug abuse by enriching the environment with alternative nondrug reinforcers. In: Green L, Kagel JH, Green L, Kagel JH, eds. Advances in behavioral economics, Vol. 3: substance use and abuse. Westport, CT, US: Ablex Publishing; 1996:37–68.
  • Daughters SB, Braun AR, Sargeant MN, et al. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). J Clin Psychiatry 2008;69:122.
  • Magidson JF, Gorka SM, MacPherson L, et al. Examining the effect of the life enhancement treatment for substance use (LETS ACT) on residential substance abuse treatment retention. Addict Behav 2011;36:615–623.
  • MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol 02/01/2010;78:55–61.
  • Barlow DH, Farchione TJ, Fairholme CP, et al. Unified protocol for transdiagnostic treatment of emotional disorders: therapist guide. New York, NY, US: Oxford University Press; 2011.
  • Norton PJ. Group cognitive-behavioral therapy of anxiety: a transdiagnostic treatment manual. New York: Guilford Press; 2012.
  • National Institute on Drug Abuse 2016–2020 Strategic Plan. 2016; Available from: https://www.drugabuse.gov/sites/default/files/2016-2020nidastrategicplan.pdf.
  • Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013;11:126.
  • Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion–smoking comorbidity. Psychol Bull 2015;141:176.
  • Bailey K, Webster R, Baker AL, Kavanagh DJ. Exposure to dysfunctional parenting and trauma events and posttraumatic stress profiles among a treatment sample with coexisting depression and alcohol use problems. Drug Alcohol Rev 2012;31:529–537.
  • Dore G, Mills K, Murray R, Teesson M, Farrugia P. Post‐traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Rev 2012;31:294–302.
  • Watson D, Tellegen A. Toward a consensual structure of mood. Psychol Bull 1985;98:219.
  • Witkiewitz K, Villarroel NA. Dynamic association between negative affect and alcohol lapses following alcohol treatment. J Consult Clin Psychol 2009;77:633.
  • Baker TB, Piper ME, McCarthy DE, Majeskie MR. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 01/2004 2004;111:33–51.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition. Washington, DC: American Psychiatric Publishing; 2013.
  • Zimmerman M, McGlinchey JB, Young D, Chelminski I. Diagnosing major depressive disorder I: A psychometric evaluation of the DSM-IV symptom criteria. J Nerv Mental Dis 2006;194:158–163.
  • Zimmerman M, McGlinchey JB, Young D, Chelminski I. Diagnosing major depressive disorder III: can some symptoms be eliminated from the diagnostic criteria? J Nerv Mental Dis 2006;194:313–317.
  • Hatzigiakoumis DS, Martinotti G, Giannantonio MD, Janiri L. Anhedonia and substance dependence: clinical correlates and treatment options. Front Psychiatry 2011;2.
  • Sussman S, Leventhal A. Substance misuse prevention: addressing anhedonia. new directions for youth development. Spring2014; 2014:45–56.
  • Leventhal AM, Brightman M, Ameringer KJ, et al. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp Clin Psychopharmacol 2010;18:562–569568.
  • Langdon KJ, Leventhal AM, Stewart S, Rosenfield D, Steeves D, Zvolensky MJ. Anhedonia and anxiety sensitivity: prospective relationships to nicotine withdrawal symptoms during smoking cessation. J Stud Alcohol Drugs 2013;74:469–478 410p.
  • Leventhal AM, Waters AJ, Kahler CW, Ray LA, Sussman S. Relations between anhedonia and smoking motivation. Nicotine Tob Res 2009: ntp098.
  • Janiri L, Martinotti G, Dario T, et al. Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology 2005;52:37–44.
  • Martinotti G, Cloninger CR, Janiri L. Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. Am J Drug Alcohol Abuse 2008;34:177–183 177.
  • Dorard GSOMC. Affect dysregulation in cannabis abusers. Eur Child Adolesc Psychiatry 08//2008; 17:274–282.
  • Garfield JB, Lubman DI, Yücel M. Anhedonia in substance use disorders: A systematic review of its nature, course and clinical correlates. Aust N Z J Psychiatry 2014;48:36–51.
  • Lichlyter B, Purdon S, Tibbo P. Predictors of psychosis severity in individuals with primary stimulant addictions. Addict Behav 2011;36:137–139.
  • Dawes GM, Sitharthan T, Conigrave KM, Phung N, Weltman M. Patients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbidities. J Subst Use 2011;16:392–405.
  • Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 2004;13:248–255.
  • AhnAllen CG, Liverant GI, Gregor KL, et al. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Res 2012;196:9–14.
  • Cook JW, Spring B, McChargue D, Hedeker D. Hedonic capacity, cigarette craving, and diminished positive mood. Nicotine Tob Res 2004;6:39–47.
  • Leventhal AM, Munafò M, Tidey JW, et al. Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers. Psychopharmacology 2012;222:343–351.
  • Nolen-Hoeksema S, Wisco BE, Lyubomirsky S. Rethinking Rumination. Perspect Psychol Sci 2008;3:400–424.
  • Osilla KC, Hepner KA, Muñoz RF, Woo S, Watkins K. Developing an integrated treatment for substance use and depression using cognitive–behavioral therapy. J Subst Abuse Treat 12//2009;37:412–420.
  • Lyubomirsky S, Caldwell ND, Nolen-Hoeksema S. Effects of ruminative and distracting responses to depressed mood on retrieval of autobiographical memories. J Personality Soc Psychol 1998;75:166.
  • Nolen-Hoeksema S, Susan N-H, Zaje AH. Rumination, depression, and alcohol use: tests of gender differences. J Cognit Psychotherapy 12/01 2002;16:391.
  • Barnhofer T, Brennan K, Crane C, Duggan D, Williams JMG. A comparison of vulnerability factors in patients with persistent and remitting lifetime symptom course of depression. J Affect Disord 2014;152:155–161.
  • Spinhoven P, Drost J, de Rooij M, van Hemert AM, Penninx BW. A longitudinal study of experiential avoidance in emotional disorders. Behav Therapy 2014;45:840–850.
  • Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev Jan 2004;111:33–51.
  • Gratz KL, Tull MT. The Relationship between emotion dysregulation and deliberate self-harm among inpatients with substance use disorders. Cognit Ther Res Dec 1 2010;34:544–553.
  • Wenzlaff RM, Wegner DM. Thought suppression. Annu Rev Psychol 2000;51:59–91.
  • Levin ME, Hildebrandt MJ, Lillis J, Hayes SC. The impact of treatment components suggested by the psychological flexibility model: a meta-analysis of laboratory-based component studies. Behav Therapy Dec 2012;43:741–756.
  • Gross JJ. Emotion regulation: Affective, cognitive, and social consequences. Psychophysiology 2002;39:281–291.
  • Joormann J, Quinn ME. Cognitive processes and emotion regulation in depression. Depression Anxiety 2014;31:308–315.
  • Gratz KL, Tull MT. The relationship between emotion dysregulation and deliberate self-harm among inpatients with substance use disorders. Cognit Therapy Res 2010;34:544–553.
  • Tull MT, Weiss NH, Adams CE, Gratz KL. The contribution of emotion regulation difficulties to risky sexual behavior within a sample of patients in residential substance abuse treatment. Addict Behav 05/22 2012;37:1084–1092.
  • Tice DM, Bratslavsky E, Baumeister RF. Emotional distress regulation takes precedence over impulse control: If you feel bad, do it! J Personality Soc Psychol 2001;80:53.
  • Baumeister RF, Heatherton TF, Tice DM. Losing control: How and why people fail at self-regulation. San Diego, CA: Academic Press; 1994.
  • Berking M, Wirtz CM, Svaldi J, Hofmann SG. Emotion regulation predicts symptoms of depression over five years. Behav Res Therapy 2014;57:13–20.
  • Berking M, Margraf M, Ebert D, Wupperman P, Hofmann SG, Junghanns K. Deficits in emotion-regulation skills predict alcohol use during and after cognitive–behavioral therapy for alcohol dependence. J Consult Clin Psychol 2011;79:307.
  • Leyro TM, Zvolensky MJ, Bernstein A. Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults. Psychol Bull 2010;136:576.
  • Bornovalova MA, Gratz KL, Daughters SB, Hunt ED, Lejuez C. Initial RCT of a distress tolerance treatment for individuals with substance use disorders. Drug Alcohol Depend 2012;122:70–76.
  • Anestis MD, Tull MT, Bagge CL, Gratz KL. The moderating role of distress tolerance in the relationship between posttraumatic stress disorder symptom clusters and suicidal behavior among trauma exposed substance users in residential treatment. Arch Suicide Res 2012;16:198–211.
  • Buckner JD, Keough ME, Schmidt NB. Problematic alcohol and cannabis use among young adults: The roles of depression and discomfort and distress tolerance. Addict Behav 2007;32:1957–1963.
  • Dennhardt AA, Murphy JG. Associations between depression, distress tolerance, delay discounting, and alcohol-related problems in European American and African American college students. Psychol Addict Behav 2011;25:595.
  • Ellis AJ, Fischer KM, Beevers CG. Is dysphoria about being red and blue? Potentiation of anger and reduced distress tolerance among dysphoric individuals. Cognit Emotion 2010;24:596–608.
  • Gorka SM, Ali B, Daughters SB. The role of distress tolerance in the relationship between depressive symptoms and problematic alcohol use. Psychol Addict Behav 2012;26:621.
  • Tull MT, Gratz KL. Major depression and risky sexual behavior among substance dependent patients: The moderating roles of distress tolerance and gender. Cognit Therapy Res 2013;37:483–497.
  • Ali B, Ryan JS, Beck KH, Daughters SB. Trait aggression and problematic alcohol use among college students: the moderating effect of distress tolerance. Alcohol Clin Exp Res 2013;37:2138–2144.
  • Allan NP, Macatee RJ, Norr AM, Raines AM, Schmidt NB. Relations between common and specific factors of anxiety sensitivity and distress tolerance and fear, distress, and alcohol and substance use disorders. J Anx Disord 2015;33:81–89.
  • Williams CL, Vik PW, Wong MM. Distress tolerance in social versus solitary college student drinkers. Addict Behav 2015;50:89–95.
  • Wolitzky‐Taylor K, Guillot CR, Pang RD, et al. Examination of anxiety sensitivity and distress tolerance as transdiagnostic mechanisms linking multiple anxiety pathologies to alcohol use problems in adolescents. Alcohol Clin Exp Res 2015;39:532–539.
  • Banducci AN, Hoffman EM, Lejuez C, Koenen KC. The impact of childhood abuse on inpatient substance users: specific links with risky sex, aggression, and emotion dysregulation. Child Abuse Neglect 2014;38:928–938.
  • Duranceau S, Fetzner MG, Carleton RN. Low distress tolerance and hyperarousal posttraumatic stress disorder symptoms: a pathway to alcohol use? Cognit Therapy Res 2014;38:280–290.
  • Howell AN, Leyro TM, Hogan J, Buckner JD, Zvolensky MJ. Anxiety sensitivity, distress tolerance, and discomfort intolerance in relation to coping and conformity motives for alcohol use and alcohol use problems among young adult drinkers. Addict Behav 2010;35:1144–1147.
  • Stein MD, Herman DS, Moitra E, et al. A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine. Drug Alcohol Depend 2015;147:243–250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.